Navigation Links
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Date:1/31/2011

h electroporation delivery of WT1 antigens with the goal of stimulating high and durable levels of immune responses, critical for improving clinical outcomes.

The principal investigator of this study, Dr. Christian H. Ottensmeier, MD, PhD, Professor of Experimental Cancer Research at the University of Southampton, said, "Wilms' Tumor gene 1 has emerged as one of the most promising targets for immunotherapy of blood malignancies including chronic myeloid leukemia (CML) and acute myeloid leukemia (AML). We previously reported strong immune responses in our prostate cancer vaccine trial using a similar DNA-electroporation approach. In that trial, patients with relapsed prostate cancer showed vaccine-induced immune responses that persisted to the end of the trial follow-up at 18 months. We are excited to extend this promising vaccine approach to CML and AML, for which better treatment options are sorely needed. This trial will evaluate the WT1 DNA vaccine in two parallel settings with the purpose of identifying the most promising path forward for a pivotal Phase 3 clinical trial."

Dr. David Grant, Scientific Director of Leukaemia and Lymphoma Research said: "It is an important step for us to see the laboratory work on DNA vaccines that LLR has supported take the next logical step into clinical testing. The trial has undergone extensive international peer review and we are delighted to see this trial in leukemia go ahead. We believe that this vaccine has real promise to improve outcomes in patients with leukemia."

The single dose level, Phase 2 study, called "WT1 immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation," led by Professor Ottensmeier and Dr. Katy Rezvani of Imperial College London and Hammersmith Hospital, London, is designed to recruit two patient groups. One group is planned to recruit up to 37 CML patients and the other up to 37 AML patients. All p
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
2. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGRĀ® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
3. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
4. Stereotaxis Announces Global Initial Training Site at University of Chicago
5. SurgiCount Medical Announces the Successful Implementation of the Safety-SpongeĀ® System at the University of Michigan Health System
6. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
7. The University of Tennessee Medical Center and ContinuumRx Form Healthcare Joint Venture
8. D3 Radiation Oncology Solutions has Completed Collaborative Commissioning of Two Varian TrueBeam Medical Linear Accelerators at the John Theurer Cancer Center, Hackensack University Medical Center
9. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
10. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
11. Siemens Wins $25 Million Contract From Rush University Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... , January 15, 2014 BreedIT ... the exclusive worldwide distributor of highly sophisticated agro-breeding solutions ... January 7, 2014, the Company,s board of directors appointed ... as its new member of the board. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... 2011 The New Jersey Patient Care and Access Coalition ... encourages men and their families to speak out to preserve ... Force (USPSTF) recommended healthy men should no longer receive prostate-specific ... This decision was made by a panel ...
... 2011 Masimo (NASDAQ: ... Japanese Ministry of Health Labor & Welfare (MHLW) ... rainbow® Acoustic Monitoring technology—providing noninvasive and continuous acoustic ... and enhance patient compliance.  Available for the first ...
Cached Medicine Technology:NJ Docs Say Cancer Detection Tool Saves Lives 2Masimo rainbow Acoustic Monitoring Technology Cleared for Market in Japan 2Masimo rainbow Acoustic Monitoring Technology Cleared for Market in Japan 3Masimo rainbow Acoustic Monitoring Technology Cleared for Market in Japan 4Masimo rainbow Acoustic Monitoring Technology Cleared for Market in Japan 5Masimo rainbow Acoustic Monitoring Technology Cleared for Market in Japan 6
(Date:4/18/2014)... (Seattle, WA April 18, 2014) Benaroya Research ... to research how blocking a particular molecule in metastatic ... and the number of lung metastases. BRI scientists have ... protein can shrink tumors by 60 - 80 percent ... to the lung. The $1.8 million five-year grant comes ...
(Date:4/18/2014)... discovery by Northwestern Medicine scientists could lead to potential ... in people with scleroderma. , Fibrosis, or scarring, ... of the skin and lungs can lead to serious ... concept for new therapeutic options centers on findings made ... who identified the role that a specific protein plays ...
(Date:4/17/2014)... new pain relief targets that could be used ... at King,s College London made the discovery when ... periphery of the body. , Dr Marzia Malcangio ... underlying pain generation and our findings could help ... , One potential side effect of some chemotherapy ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2
... Herley Industries, Inc. (Nasdaq: HRLY ) announced today ... contracts valued at approximately $4 million to provide various complex ... follow-on awards for an existing customer and program. The hardware ... , , Herley Industries, Inc. acquired Eyal Microwave Industries, ...
... before prescribing, researcher says , THURSDAY, June 4 (HealthDay ... the elderly, Swedish researchers say. , In their study, ... of suicides in older people. "Sedative treatment was associated ... the crude analysis and remained an independent risk factor ...
... London, New Delhi, Singapore and Washington DC (4 June, ... journal Palliative Medicine is to become the ... Formed in 1986, The Association for Palliative Medicine of ... doctors who work in hospices and specialist palliative care ...
... French . , Montreal, June 4th, 2009 ... a disease that results in severe breathing difficulty. According to ... worldwide. However the mechanisms responsible for some smokers developing COPD ... Dr.Manuel Cosio from the McGill University Health Centre, ...
... Frontiers in Labor and Employment Relations: Ensuring Good Jobs, ... , , , WASHINGTON, June 4 ... Employment Relations Association on June 11-12, 2009, features the ... on the auto crisis, top national experts on health ...
... The Usual With A Gift That Does Wonders For His ... , PACIFIC PALISADES, Calif., June 4 Forget ties ... he secretly desires but may not buy for himself: An ... hero. Dermagenics Physician-Formulated Anti-Wrinkle Moisturizer is an ...
Cached Medicine News:Health News:Herley's Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer 2Health News:Sedatives Increase Suicide Risk Among Elderly 2Health News:Investigation finds that cigarette smoking does not affect everyone in same way 2Health News:LERA National Policy Forum Set for June 11-12 in Washington, D.C. 2Health News:LERA National Policy Forum Set for June 11-12 in Washington, D.C. 3Health News:SHOW DAD YOU LOVE HIS FACE 2
... 1300 C is ideal for evaluating a wide ... parts of the body. Often referred to at ... magnetocardiography, gastrointestinal tract, fetal, spinal cord and peripheral ... C, with its 67 detector coils, covers a ...
... table configurations designed for a wide range ... capture 17 X 17 X-ray images from ... system includes a Bucky table, upright tilting ... suspended multi-positioning unit. Versatile and economical, the ...
... synthetic bone filler tailored for slow ... and Hydroxyapatite (HAP), its composition mimics ... the chemistry and microstructure of Bi-Ostetic ... provides optimal osteo-conduction. The spongy Bi-Ostetic ...
The TB Lead is a high quality bipolar intracardiac lead for cost effective temporary pacing and electrophysiology studies. The TB lead is available in sizes ranging from 4F to 6F and comes in either ...
Medicine Products: